Smoking cessation aids 2010

Back to list of bulletin subject headings

Research from 17 December 2010

  • Balmford, J., Borland, R., Hammond, D., and Cummings, K. M. Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC four-country survey. Nicotine.Tob.Res.  8-12-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/21147894
  • Cahill, K., Stead, L. F., and Lancaster, T. Nicotine receptor partial agonists for smoking cessation. Cochrane.Database.Syst.Rev. 12, CD006103. 2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/21154363
  • Hays, J. T. and Ebbert, J. O. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence. Drugs 70[18], 2357-2372. 24-12-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/21142259
  • Onizawa, S., Taniguchi, H., Nozu, T., Asano, A., Katsura, H., Saiki, K., Kiguchi, T., Hasegawa, M., and Nagai, A. [Sustainable efficacy of oral varenicline for smoking cessation]. Nihon Kokyuki.Gakkai Zasshi 48[11], 791-796. 2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/21141055
  • Pineiro, B., Miguez, M. D., and Becona, E. [Motivational interviewing in smoking treatment: a review.]. Adicciones. 22[4], 353-364. 2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/21152854

Research from 9 December 2010 

  • Crunelle, C. L., Schulz, S., de Bruin, K., Miller, M. L., Van Den, Brink W., and Booij, J. Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats. Eur.Neuropsychopharmacol.  2-12-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/21130610
  • Fagerstrom, K., Gilljam, H., Metcalfe, M., Tonstad, S., and Messig, M. Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial. BMJ 341, c6549. 2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/21134997

Research from 26 November 2010

  • Beard, E., McNeill, A., Aveyard, P., Fidler, J., Michie, S., and West, R. Use of nicotine replacement therapy for smoking reduction and during enforced temporary abstinence: a national survey of English smokers. Addiction . 28-9-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/21083833

Research from 19 November 2010

  • Marteau, T. M., Munafo, M. R., Aveyard, P., Hill, C., Whitwell, S., Willis, T. A., Crockett, R. A., Hollands, G. J., Johnstone, E. C., Wright, A. J., Prevost, A. T., Armstrong, D., Sutton, S., and Kinmonth, A. L. Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence. BMC Public Health [electronic resource] 10[1], 680. 9-11-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/21062464

Research from 11 November 2010

  • Carroll FI, Blough BE, Mascarella SW, Navarro HA, Eaton JB, Lukas RJ, Damaj MI. Nicotinic Acetylcholine Receptor Efficacy and Pharmacological Properties of 3-(Substituted phenyl)-2ß-substituted Tropanes. J Med Chem. 2010 Nov 8. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/21058665
  • Ebbert JO, Wyatt KD, Hays JT, Klee EW, Hurt RD. Varenicline for smoking cessation: efficacy, safety, and treatment recommendations. Patient Prefer Adherence. 2010 Oct 5;4:355-62. Abstract or full text available at:  http://www.ncbi.nlm.nih.gov/pubmed/21049087
  • Lindson N, Aveyard P. An updated meta-analysis of nicotine preloading for smoking cessation: investigating mediators of the effect. Psychopharmacology (Berl). 2010 Nov 9. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/21060996
  • Rollema H, Wilson GG, Lee TC, Folgering JH, Flik G. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex. Neurochem Int. 2010 Nov 4. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/21056607
  • Johnson TS. A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline. J Am Acad Nurse Pract. 2010 Oct;22(10):557-63 Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/221040090
  • Tonstad S, Holme I, Tønnesen P. Dianicline, a Novel {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Partial Agonist, for Smoking Cessation: A Randomized Placebo-Controlled Clinical Trial. Nicotine and Tobacco Research. 2010 Nov 1. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/21041839

Research from 4 November 2010

  • Zimovetz EA, Wilson K, Samuel M, Beard SM. A review of cost-effectiveness of  varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities Journal of Evaluation in Clinical Practice. Oct 4.2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/21029268

Research from 22 October 2010

  • Steinberg, M. B., Bover, M. T., Richardson, D. L., Schmelzer, A. C., Williams, J. M., and Foulds, J. Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies. Drug and Alcohol Dependence . 14-10-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20951511
  • Hays, J. T., Croghan, I. T., Schroeder, D. R., Ebbert, J. O., and Hurt, R. D. Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: An open-label pilot study. J.Subst.Abuse Treat.  12-10-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20947286
  • Gray, K. M., Carpenter, M. J., Baker, N. L., Hartwell, K. J., Lewis, A. L., Hiott, D. W., Deas, D., and Upadhyaya, H. P. Bupropion SR and contingency management for adolescent smoking cessation. J.Subst.Abuse Treat.  8-10-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20934835
  • Barnes, J., Dong, C. Y., McRobbie, H., Walker, N., Mehta, M., and Stead, L. F. Hypnotherapy for smoking cessation. Cochrane Database of Systematic Reviews 10, CD001008. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20927723
  • George, O., Lloyd, A., Carroll, F. I., Damaj, M. I., and Koob, G. F. Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration. Psychopharmacology (Berl) . 6-10-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20924754


Research from 8 October 2010

  • Jung, J. W., Jeon, E. J., Kim, J. G., Yang, S. Y., Choi, J. C., Shin, J. W., Park, I. W., Choi, B. W., Kim, D. K., and Kim, J. Y. Clinical experience of varenicline for smoking cessation. Clin.Respir.J. 4[4], 215-221. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20887344
  • Zeng, F., Chen, C. I., Mastey, V., Zou, K. H., Harnett, J., and Patel, B. V. Utilization management for smoking cessation pharmacotherapy: varenicline rejected claims analysis. Am.J.Manag.Care 16[9], 667-674. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20873954

Research from 30 September 2010

  • Smith, M. W., Chen, S., Siroka, A. M., and Hamlett-Berry, K. Using policy to increase prescribing of smoking cessation medications in the VA healthcare system. Tobacco Control . 24-9-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20870742
  • Ortega, F., Vellisco, A., Marquez, E., Lopez-Campos, J. L., Rodriguez, A., Los Angeles, Sanchez M., Barrot, E., and Cejudo, P. [Effectiveness of a cognitive orientation program with and without nicotine replacement therapy in stopping smoking in hospitalised patients.]. Archivos de Bronconeumología . 24-9-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20870337
  • Tashkin, D. P., Rennard, S., Hays, J. T., Ma, W., Lawrence, D., and Lee, T. C. Effects of varenicline on smoking cessation in mild-to-moderate COPD: a randomized controlled trial. Chest . 23-9-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20864613

Research from 17 September 2010

  • Ferentinos, P., Christodoulou, C., Rizos, E., Douzenis, A., and Lykouras, L. Mixed-Type (Limb-Truncal and Orofacial) Bupropion-Associated Dyskinesia. J.Clin.Psychopharmacol. 30[5], 644-646. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20841971
  • Saracino, M. A., Marcheselli, C., Somaini, L., Gerra, G., De Stefano, F., Pieri, M. C., and Raggi, M. A. Simultaneous determination of disulfiram and bupropion in human plasma of alcohol and nicotine abusers. Anal.Bioanal.Chem.  12-9-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20835865
  • Mazure, C. M., Toll, B., McKee, S. A., Wu, R., and O'Malley, S. S. Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion. Drug and Alcohol Dependence . 9-9-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20832955
  • Konstantinidis, I., Chatziavramidis, A., Printza, A., Metaxas, S., and Constantinidis, J. Effects of smoking on taste: Assessment with contact endoscopy and taste strips. Laryngoscope . 9-9-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20830760
  • Garelik, D. A. Nicotine gum dependence treated with varenicline--A case report. Nicotine.Tob.Res.  9-9-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20829327
  • Javors, M. A., Hatch, J. P., and Lamb, R. J. Sequential combination of self-report, breath carbon monoxide, and saliva cotinine to assess smoking status. Drug and Alcohol Dependence . 3-9-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20822867

Research from 10 September 2010

  • Gonzales, D., Jorenby, D. E., Brandon, T. H., Arteaga, C., and Lee, T. C. Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo. Addiction . 1-9-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20819082
  • Keating, G. M. and Lyseng-Williamson, K. A. Pharmacoeconomic spotlight on varenicline as an aid to smoking cessation dagger. CNS.Drugs 24[9], 797-800. 1-9-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20806990


Research from 3 September 2010

  • Cavallo, D. A., Nich, C., Schepis, T. S., Smith, A. E., Liss, T. B., McFetridge, A. K., and Krishnan-Sarin, S. Preliminary examination of adolescent spending in a contingency management based smoking cessation program. J.Child Adolesc.Subst.Abuse 19[4], 335-342. 1-9-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20802850


Research from 27 August 2010

  • Poling, J., Rounsaville, B., Gonsai, K., Severino, K., and Sofuoglu, M. The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study. Am.J.Addict. 19[5], 401-408. 2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20716302

Research from 20 August 2010

  • Paterson, N. E., Min, W., Hackett, A., Lowe, D., Hanania, T., Caldarone, B., and Ghavami, A. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats. Prog.Neuropsychopharmacol.Biol.Psychiatry . 10-8-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20708056

Research from 6 August 2010

  • Fagerstrom, K., Nakamura, M., Cho, H. J., Tsai, S. T., Wang, C., Davies, S., Ma, W., Lee, T. C., and Russ, C. Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries. Curr.Med.Res.Opin.  29-7-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20666691

Research from 30 July 2010

  • DeVeaugh-Geiss, A. M., Chen, L. H., Kotler, M. L., Ramsay, L. R., and Durcan, M. J. Pharmacokinetic comparison of two nicotine transdermal systems, a 21-mg/24-hour patch and a 25-mg/16-hour patch: a randomized, open-label, single-dose, two-way crossover study in adult smokers. Clin.Ther. 32[6], 1140-1148. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20637967
  • Ferguson, S. G. and Shiffman, S. Effect of high-dose nicotine patch on the characteristics of lapse episodes. Health Psychol. 29[4], 358-366. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20658822
  • Leventhal, A. M., David, S. P., Brightman, M., Strong, D., McGeary, J. E., Brown, R. A., Lloyd-Richardson, E. E., Munafo, M., Uhl, G. R., and Niaura, R. Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. Pharmacogenomics Journal . 27-7-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20661272
  • Liu, Y., Bao, Y. P., Sun, H. Q., Beveridge, T. J., Li, S. X., Di, X. L., Yang, F. D., and Lu, L. Long-term treatment with aripiprazole on the waking and postprandial urges to smoke in Chinese heavy smokers. J.Clin.Psychopharmacol. 30[4], 373-380. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20631555
  • Mills, E. J., Wu, P., Lockhart, I., Wilson, K., and Ebbert, J. O. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tob.Induc.Dis. 8[1], 8. 13-7-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20626883
  • Moore, T. J., Glenmullen, J., and Furberg, C. D. Thoughts and acts of aggression/violence toward others reported in association with Varenicline(September). Ann.Pharmacother.  20-7-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20647416
  • Weinberger, A. H., McKee, S. A., and George, T. P. Changes in smoking expectancies in abstinent, reducing, and non-abstinent participants during a pharmacological trial for smoking cessation. Nicotine.Tob.Res.  19-7-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20644207

Research from 8 July 2010

  • Hemauer, S. J., Patrikeeva, S. L., Wang, X., Abdelrahman, D. R., Hankins, G. D., Ahmed, M. S., and Nanovskaya, T. N. Role of transporter-mediated efflux in the placental biodisposition of bupropion and its metabolite, OH-bupropion. Biochem.Pharmacol.  23-6-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20599802
  • Sood, A., Ebbert, J. O., Prasad, K., Croghan, I. T., Bauer, B., and Schroeder, D. R. A randomized clinical trial of St. John's Wort for smoking cessation. J.Altern.Complement Med.  30-6-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20590478

Research from 2 July 2010

  • Buchanan, L. M. and Khazanchi, D. A PDA intervention to sustain smoking cessation in clients with socioeconomic vulnerability. West J.Nurs.Res. 32[3], 281-304. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20581398
  • Damaj, M. I., Grabus, S. D., Navarro, H. A., Vann, R. E., Warner, J. A., King, L. S., Wiley, J. L., Blough, B. E., Lukas, R. J., and Carroll, F. I. Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice. J.Pharmacol.Exp.Ther.  24-6-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20576796


Research from 25 June 2010

  • Burns, E. K., Tong, S., and Levinson, A. H. Reduced NRT supplies through a quitline: Smoking cessation differences. Nicotine.Tob.Res.  18-6-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20562205
  • Epperson, C. N., Toll, B., Wu, R., Amin, Z., Czarkowski, K. A., Jatlow, P., Mazure, C. M., and O'Malley, S. S. Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch. Drug and Alcohol Dependence . 17-6-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20561758


Research from 18 June 2010

  • Kikkawa, H., Maruyama, N., Fujimoto, Y., and Hasunuma, T. Single- and multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy Japanese adult smokers. Journal of Clinical Pharmacology . 15-6-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20551220
  • Singh, P. and Kumar, R. Assessment of the effectiveness of sustained release Bupropion and intensive physician advice in smoking cessation. Lung India 27[1], 11-18. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20539765

Research from 11 June 2010

  • Bullen, C., Howe, C., Lin, R. B., Grigg, M., Laugesen, M., McRobbie, H., Glover, M., Walker, N., Wallace-Bell, M., Whittaker, R., and Rodgers, A. Pre-cessation nicotine replacement therapy: pragmatic randomized trial. Addiction . 7-6-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20528810
  • Gonzales, D. Nicotine patch plus lozenge gives greatest increases in abstinence from smoking rates at 6 months compared with placebo; smaller effects seen with nicotine patch alone, bupropion or nicotine lozenges alone or combined. Evid.Based.Med. 15[3], 77-78. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20522682
  • Tonstad, S. and Rollema, H. Varenicline in smoking cessation. Expert.Rev.Respir.Med. 4[3], 291-299. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20524911
  • Tundulawessa, Y., Yongchaiyud, P., Chutrthong, W., and Tundulawessa, K. The bioequivalent and effect of nicotine formulation gum on smoking cessation. J.Med.Assoc.Thai. 93[5], 574-579. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20524443
  • Vidrine, J. I., Rabius, V., Alford, M. H., Li, Y., and Wetter, D. W. Enhancing dissemination of smoking cessation quitlines through T2 translational research: a unique partnership to address disparities in the delivery of effective cessation treatment. J.Public Health Manag.Pract. 16[4], 304-308. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20520368


Research from 4 June 2010

  • Botello-Harbaum, M., Schroeder, J. R., Collins, C. C., and Moolchan, E. T. Nicotine replacement therapy use among adolescent smokers seeking cessation treatment. Ethnicity and Disease 20[2], 180-184. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20503900
  • Lukas, R. J., Muresan, A. Z., Damaj, M. I., Blough, B. E., Huang, X., Navarro, H. A., Mascarella, S. W., Eaton, J. B., Marxer-Miller, S. K., and Carroll, F. I. Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: aids to smoking cessation. J.Med.Chem.  28-5-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20509659

Research from 28 May 2010

  • McRobbie, H., Thornley, S., Bullen, C., Lin, R. B., Senior, H., Laugesen, M., Whittaker, R., and Hajek, P. A randomized trial of the effects of two novel nicotine replacement therapies on tobacco withdrawal symptoms and user satisfaction. Addiction . 14-5-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20491724
  • Perkins, K. A., Lerman, C., Fonte, C. A., Mercincavage, M., Stitzer, M. L., Chengappa, K. N., and Jain, A. Cross-Validation of a New Procedure for Early Screening of Smoking Cessation Medications in Humans. Clin.Pharmacol.Ther.  19-5-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20485335

Research for 21 May 2010

  • Harrington, K. F. and Bailey, W. C. Smoking cessation through the utilization of pharmacotherapy. Expert.Rev.Respir.Med. 3[5], 475-485. 2009.  Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20477338
  • Nicotine patch plus nicotine lozenges increased smoking cessation rate more than placebo. Ann.Intern.Med. 152[10], JC52. 18-5-2010.  Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20479019
  • Macaluso, M., Zackula, R., D'Empaire, I., Baker, B., Liow, K., and Preskorn, S. H. Twenty percent of a representative sample of patients taking bupropion have abnormal, asymptomatic electroencephalographic findings. J.Clin.Psychopharmacol. 30[3], 312-317. 2010.  Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20473069
  • Murray, H. W., McHugh, R. K., Rowley, T. C., Sirota, A. D., and Otto, M. W. Development and Validation of the Smoking Cue Appeal Survey. Subst.Use.Misuse.  14-5-2010.  Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20469971
  • Hizue, M., Ishibashi, T., and Nomura, S. [Pharmacological profile and clinical findings of varenicline tartrate (Champix tablets)]. Nippon Yakurigaku Zasshi 135[5], 194-203. 2010.  Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20467169
  • Cobb, N. K., Graham, A. L., and Abrams, D. B. Social Network Structure of a Large Online Community for Smoking Cessation. Am.J.Public Health . 13-5-2010.  Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20466971
  • Zhao, Q., Schwam, E., Fullerton, T., O'Gorman, M., and Burstein, A. H. Pharmacokinetics, Safety, and Tolerability Following Multiple Oral Doses of Varenicline Under Various Titration Schedules in Elderly Nonsmokers. J.Clin.Pharmacol.  13-5-2010.  Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20466870 

Research from 14 May 2010

  • Biala, G. and Staniak, N. Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice. Pharmacol.Biochem.Behav.  5-5-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20451547
  • Hays, J. T., Leischow, S. J., Lawrence, D., and Lee, T. C. Adherence to treatment for tobacco dependence: Association with smoking abstinence and predictors of adherence. Nicotine.Tob.Res.  10-5-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20457644

Research from 7 May 2010

  • Cole, D. M., Beckmann, C. F., Long, C. J., Matthews, P. M., Durcan, M. J., and Beaver, J. D. Nicotine replacement in abstinent smokers improves cognitive withdrawal symptoms with modulation of resting brain network dynamics. Neuroimage.  1-5-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20441798
  • Gillman, P. K. Bupropion, Bayesian Logic and Serotonin Toxicity. J.Med.Toxicol.  4-5-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20440594
  • Buchanan, L. Nicotine patch plus lozenge gives greatest increases in abstinence from smoking at 6 months compared with placebo; smaller effects seen with nicotine patch alone, bupropion or nicotine lozenges alone or combined. Evid.Based.Nurs. 13[2], 50-51. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20436150
  • Tsoi, D. T., Porwal, M., and Webster, A. C. Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis. Br.J.Psychiatry 196[5], 346-353. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20435957
  • Turner, J. R., Castellano, L. M., and Blendy, J. A. Nicotinic Partial Agonists, Varenicline and Sazetidine-A, have Differential Effects on Affective Behavior. J.Pharmacol.Exp.Ther.  30-4-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20435920
  • McClure, J. B., Ludman, E. J., Grothaus, L., Pabiniak, C., and Richards, J. Impact of spirometry feedback and brief motivational counseling on long-term smoking outcomes: A comparison of smokers with and without lung impairment. Patient.Educ.Couns.  29-4-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20434863

Research from 30 April 2010

  • Boora, K., Cummings, M. R., and Marshall, D. R. Generalized seizure in three adolescents with bupropion overdose. J.Child Adolesc.Psychopharmacol. 20[2], 159-160. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20415613
  • Egleston, B. L., Cropsey, K. L., Lazev, A. B., and Heckman, C. J. A tutorial on principal stratification-based sensitivity analysis: application to smoking cessation studies. Clin.Trials . 27-4-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20423924
  • Swan, G. E., McClure, J. B., Jack, L. M., Zbikowski, S. M., Javitz, H. S., Catz, S. L., Deprey, M., Richards, J., and McAfee, T. A. Behavioral counseling and varenicline treatment for smoking cessation. Am.J.Prev.Med. 38[5], 482-490. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20409497
  • Tang, H., Abramsohn, E., Park, H. Y., Cowling, D. W., and Al Delaimy, W. K. Using a cessation-related outcome index to assess California's cessation progress at the population level. Tobacco Control 19 Suppl 1, i56-i61. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20382652


Research from 23 April 2010

  • Aggarwal, A., Jain, M., and Jiloha, R. C. Varenicline for smokeless tobacco dependence. J.Postgrad.Med. 56[1], 50. 2010. Abstract or full text available at:  http://www.ncbi.nlm.nih.gov/pubmed/20393259
  • Ebbert, J. O., Hays, J. T., and Hurt, R. D. Combination pharmacotherapy for stopping smoking: what advantages does it offer? Drugs 70[6], 643-650.  16-4-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20394453
  • Lancaster, T. and Stead, L. Extended-duration transdermal nicotine therapy was more effective than standard-duration therapy for smoking cessation. Ann.Intern.Med. 152[8], JC4-JC8. 20-4-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20404377
  • Rudnick, N. D., Strasser, A. A., Phillips, J. M., Jepson, C., Patterson, F., Frey, J. M., Turetsky, B. I., Lerman, C., and Siegel, S. J. Mouse model predicts effects of smoking and varenicline on event-related potentials in humans. Nicotine.Tob.Res.  15-4-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20395358

Research from 16 April 2010

  • Earhart, A. D., Patrikeeva, S., Wang, X., Reda, Abdelrahman D., Hankins, G. D., Ahmed, M. S., and Nanovskaya, T. Transplacental transfer and metabolism of bupropion. Journal of Maternal, Fetal & Neonatal Medicine 23[5], 409-416. 2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20377481
  • Biazzo, L. L., Froshaug, D. B., Harwell, T. S., Beck, H. N., Haugland, C., Campbell, S. L., and Helgerson, S. D. Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy. Nicotine.Tob.Res.  8-4-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20378640
  • Cummings, K. M., Fix, B. V., Celestino, P., Hyland, A., Mahoney, M., Ossip, D. J., and Bauer, U. Does the number of free nicotine patches given to smokers calling a quitline influence quit rates: results from a quasi-experimental study. BMC Public Health [electronic resource] 10[1], 181. 7-4-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20374628
  • Rose, J. Phd, Behm, FM Cra, Drgon, T. Phd, Johnson, C. Ms, and Uhl GR, Md Phd. Personalized smoking cessation: interactions between nicotine dose, dependence and quit success genotype score. Mol.Med.  17-3-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20379614
  • Umene-Nakano, W., Yoshimura, R., Yoshii, C., Hoshuyama, T., Hayashi, K., Hori, H., Katsuki, A., Ikenouchi-Sugita, A., and Nakamura, J. Varenicline does not increase serum BDNF levels in patients with nicotine dependence. Human Psychopharmacology 25[3], 276-279. 2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20373480


Research from 9 April 2010

  • Geimer, N., Olson, C. E., Baumgarten, D., Kepner, J. L., and Mahoney, M. C. Use of a liquid nicotine delivery product to promote smoking cessation. BMC.Public Health 10[1], 155. 24-3-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20334673
  • McClure, J. B., Swan, G. E., Catz, S. L., Jack, L., Javitz, H., McAfee, T., Deprey, M., Richards, J., and Zbikowski, S. M. Smoking outcome by psychiatric history after behavioral and varenicline treatment. J.Subst.Abuse Treat.  1-4-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20363092
  • Smith, R. C., Zhubi, A., Maloku, E., Sershen, H., Lajtha, A., Davis, J. M., Costa, E., and Guidotti, A. Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers. Schizophr.Res.  22-3-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20335008

Research from 26 March 2010

  • Combined nicotine replacement therapy provides best chance of smoking cessation. Harv.Ment.Health Lett. 26[8], 7. 2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20235378
  • Jones, T. E. and Williams, J. Craving control using NRT in a teaching hospital. Intern.Med.J.  18-3-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20298509
  • Perkins, K. A., Mercincavage, M., Fonte, C. A., and Lerman, C. Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence. Psychopharmacology (Berl) . 20-3-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20306175
  • Reichel, C. M., Murray, J. E., Barr, J. D., and Bevins, R. A. Extinction with varenicline and nornicotine, but not ABT-418, weakens conditioned responding evoked by the interoceptive stimulus effects of nicotine. Neuropharmacology . 16-3-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20302882
  • Rollema, H., Shrikhande, A., Ward, K. M., Tingley Iii, F. D., Coe, J. W., O'Neill, B. T., Tseng, E., Wang, E. Q., Mather, R. J., Hurst, R. S., Williams, K. E., de Vries, M., Cremers, T., Bertrand, S., and Bertrand, D. Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. Br.J.Pharmacol.  22-3-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20331614
  • Tonstad, S., Davies, S., Flammer, M., Russ, C., and Hughes, J. Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis. Drug Saf 33[4], 289-301. 1-4-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20297861
  • Tripp, A. C. Bupropion, a brief history of seizure risk. Gen.Hosp.Psychiatry 32[2], 216-217. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20302998
  • Uhl, G. R., Drgon, T., Johnson, C., Walther, D., Aveyard, P., Murphy, M., Johnstone, E. C., and Munafo, M. R. Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. Pharmacogenomics. 11[3], 357-367. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20235792

Research from 12 March 2010

  • Loughead, J., Ray, R., Wileyto, E. P., Ruparel, K., Sanborn, P., Siegel, S., Gur, R. C., and Lerman, C. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol.Psychiatry . 5-3-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20207347
  • Laniado-Laborin, R. Smoking cessation intervention: an evidence-based approach. Postgrad.Med. 122[2], 74-82. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20203458
  • Husten, C. G. A Call for ACTTION: Increasing access to tobacco-use treatment in our nation. Am.J.Prev.Med. 38[3 Suppl], S414-S417. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20176316
  • Shiffman, S. Smoking-cessation treatment utilization: The need for a consumer perspective. Am.J.Prev.Med. 38[3 Suppl], S382-S384. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20176311
  • Abrams, D. B., Graham, A. L., Levy, D. T., Mabry, P. L., and Orleans, C. T. Boosting population quits through evidence-based cessation treatment and policy.
    Am.J.Prev.Med. 38[3 Suppl], S351-S363. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20176308

     

Research from 5 March 2010

  • Madden, G. J. and Kalman, D. Effects of bupropion on simulated demand for cigarettes and the subjective effects of smoking. Nicotine.Tob.Res.  1-3-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20194522
  • Morrison, M. F., Ceesay, P., Gantz, I., Kaufman, K. D., and Lines, C. R. Randomized, controlled, double-blind trial of taranabant for smoking cessation. Psychopharmacology (Berl) . 27-2-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20191360


Research from 26 February 2010

  • Seidman, D. F., Westmaas, J. L., Goldband, S., Rabius, V., Katkin, E. S., Pike, K. J., Wiatrek, D., and Sloan, R. P. Randomized Controlled Trial of an Interactive Internet Smoking Cessation Program with Long-Term Follow-up. Ann.Behav.Med.  23-2-2010.  Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20177844
  • Thornley, S., Jackson, G., McRobbie, H., Sinclair, S., and Smith, J. Few smokers in South Auckland access subsidised nicotine replacement therapy. N.Z.Med.J. 123[1308], 16-27. 2010.  Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20173802
  • Summaries for patients: Extended nicotine treatment for long-term smokers. Ann.Intern.Med. 152[3], I38. 2-2-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20124226

Research from 19 February 2010

  • Carroll, F. I., Blough, B. E., Mascarella, S. W., Navarro, H. A., Eaton, J. B., Lukas, R. J., and Damaj, M. I. Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for smoking cessation. J.Med.Chem.  16-2-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20158204
  • Tsukahara, H., Noda, K., and Saku, K. A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers. Circ.J.  13-2-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20154405
  • Eisenberg, M., Blum, L. M., Filion, K. B., Rinfret, S., Pilote, L., Paradis, G., Joseph, L., Gervais, A., and O'Loughlin, J. The efficacy of smoking cessation therapies in cardiac patients: A meta-analysis of randomized controlled trials. Can.J.Cardiol. 26[2], 73-79. 2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20151052

Research from 12 February 2010

  • Escobar-Chavez, J. J., Merino, V., Diez-Sales, O., Nacher-Alonso, A., Ganem-Quintanar, A., Herraez, M., and Merino-Sanjuan, M. Transdermal nortriptyline hydrocloride patch formulated within a chitosan matrix intended to be used for smoking cessation. Pharm.Dev.Technol.  9-2-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20141498
  • Raupach, T., Shahab, L., Eimer, S., Puls, M., Hasenfuss, G., and Andreas, S. Increasing the use of nicotine replacement therapy by a simple intervention: an exploratory trial. Subst.Use.Misuse. 45[3], 403-413. 2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20141455

Research from 5 February 2010

  • Croyle, R. T. Increasing the effectiveness of tobacco quitlines. J.Natl.Cancer Inst. 102[2], 72-73. 20-1-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20056954
  • Keating, G. M. and Lyseng-Williamson, K. A. Varenicline: a harmacoeconomic review of its use as an aid to smoking cessation. Pharmacoeconomics.  27-1-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20108995
  • Moreno, A. Y., Azar, M. R., Warren, N. A., Dickerson, T., Koob, G. F., and Janda, K. A critical evaluation of a nicotine vaccine within a self-administration behavioral model. Mol.Pharm.  27-1-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20104903
  • Ravva, P., Gastonguay, M. R., French, J. L., Tensfeldt, T. G., and Faessel, H. M. Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessation. Clin.Pharmacol.Ther.  27-1-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20107434
  • Schnoll, R. A., Patterson, F., Wileyto, E. P., Heitjan, D. F., Shields, A. E., Asch, D. A., and Lerman, C. Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann.Intern.Med. 152[3], 144-151. 2-2-2010. Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20124230

Research from 29 January 2010

  • Schnoll, R. A., Martinez, E., Tatum, K. L., Weber, D. M., Kuzla, N., Glass, M., Ridge, J. A., Langer, C., Miyamoto, C., Wileyto, E. P., and Leone, F. A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes Control . 20-1-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20087643

Research from 22 January 2010

  • Rao, J. and Shankar, P. K. Varenicline: for smoking cessation. Kathmandu.Univ Med.J.(KUMJ.) 7[26], 162-164. 2009.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20071853
  • Schnoll, R. A., Martinez, E., Tatum, K. L., Weber, D. M., Kuzla, N., Glass, M., Ridge, J. A., Langer, C., Miyamoto, C., Wileyto, E. P., and Leone, F. A bupropion smoking cessation clinical trial for cancer patients. Cancer Causes Control . 20-1-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20087643
  • Sood, A., Ebbert, J. O., Wyatt, K. D., Croghan, I. T., Schroeder, D. R., Sood, R., and Hays, J. T. Gabapentin for smoking cessation. Nicotine.Tob.Res.  15-1-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20081039

Research from 15 January 2010

  • Bansal-Travers, M., Cummings, K. M., Hyland, A., Brown, A., and Celestino, P. Educating smokers about their cigarettes and nicotine medications. Health Education Research . 11-1-2010.  Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20064838
  • Hudmon, K. S., Corelli, R. L., and Prokhorov, A. V. Current approaches to pharmacotherapy for smoking cessation. Ther.Adv.Respir.Dis.  7-1-2010.  Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20056740

Research from 8 January 2010

  • Apelberg, B. J., Onicescu, G., Avila-Tang, E., and Samet, J. M. Estimating the risks and benefits of nicotine replacement therapy for smoking cessation in the United States. American Journal of Public Health . 17-12-2009.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20019322
  • Ciancio, G., Colina, M., La Corte, R., Lo, Monaco A., De Leonardis, F., Trotta, F., and Govoni, M. Nicotine-patch therapy on mucocutaneous lesions of Behcet's disease: a case series. Rheumatology.(Oxford) . 16-12-2009.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20015973
  • Ebbert, J. O., Wyatt, K. D., Zirakzadeh, A., Burke, M. V., and Hays, J. Clinical utility of varenicline for smokers with medical and psychiatric comorbidity. Int.J.Chron.Obstruct.Pulmon.Dis. 4, 421-430. 2009.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20037681
  • Harrison-Woolrych, M. Varenicline and suicide. Safety data from New Zealand. BMJ 339, b5654. 2009.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20044403
  • Kroger, C. and Gradl, S. [Smoking cessation therapies in Germany.]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz . 25-12-2009.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20033664
  • Linden, K., Jormanainen, V., Linna, M., Sintonen, H., Wilson, K., and Kotomaki, T. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers. Current Medical Research and Opinion . 6-1-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20050814
  • Ockene, I. and Salmoirago-Blotcher, E. Varenicline for smoking cessation in patients with coronary heart disease. Circulation . 4-1-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20048200
  • Rigotti, N. A., Pipe, A. L., Benowitz, N. L., Arteaga, C., Garza, D., and Tonstad, S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease. a randomized trial. Circulation . 4-1-2010.
    Abstract or full text available at: http://www.ncbi.nlm.nih.gov/pubmed/20048210

Back to list of bulletin subject headings